Evidence map›Paper›PMID 41975817›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.

Abed Agbarya, Walid Shalata, Edmond Sabo, Leonard Saiegh, Yuval Shaham, Haitam Nasrallah, Kamel Mhameed, Salam Mazareb, Mohammad Sheikh-Ahmad, Dan Levy Faber

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abed AgbaryaThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 1 Efron Street, Haifa 3109601, Israel.ORCID 0000-0002-3330-2959
Walid ShalataThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, 151 Yitzhack Rager Avenue, Beer Sheva 8457108, Israel.ORCID 0000-0002-7570-4550
Edmond SaboPathology Institute, Lady Davis Carmel Medical Center, 7 Michal Street, Haifa 3436212, Israel.
Leonard SaieghInstitute of Endocrinology, Bnai-Zion Medical Center, 47 Eliyahu Golomb Avenue, Haifa 3339419, Israel.ORCID 0000-0001-5771-6569
Yuval ShahamThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 1 Efron Street, Haifa 3109601, Israel.
Haitam NasrallahThe Joseph Fishman Oncology Center, Rambam Medical Center, 6 Efron Street, Haifa 3525409, Israel.
Kamel MhameedThe Joseph Fishman Oncology Center, Rambam Medical Center, 6 Efron Street, Haifa 3525409, Israel.
Salam MazarebPathology Institute, Lady Davis Carmel Medical Center, 7 Michal Street, Haifa 3436212, Israel.
Mohammad Sheikh-AhmadThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 1 Efron Street, Haifa 3109601, Israel.
Dan Levy FaberThe Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 1 Efron Street, Haifa 3109601, Israel.ORCID 0000-0003-4558-4858

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

actionable mutationsco-mutationsdriver mutationsgenetic mutationsgenomic clusterlung cancer

Identifiers

PMID41975817
PMCPMC13073532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.